Antidepressant selection for major depressive disorder: The budgetary impact on managed care

Drug Benefit Trends

Volumn 12, Issue 5, 2000, Pages

  Casciano, R ^a   Arikian, S R ^a   Tarride, J E ^a   Casciano, J ^a   Doyle, J J ^a  

^a NONE

Author keywords

Depression; Serotonin norepinephrine reuptake inhibitors (SNRIs); SSRIs; Tricyclic antidepressants (TCAs)

Indexed keywords

AMITRIPTYLINE; DESIPRAMINE; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; NORTRIPTYLINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ARTICLE; COST EFFECTIVENESS ANALYSIS; DEPRESSION; DRUG COST; DRUG EFFICACY; DRUG UTILIZATION; HUMAN; MANAGED CARE; SUSTAINED RELEASE FORMULATION; TREATMENT OUTCOME; UTILIZATION REVIEW;

EID: 0034037523     PISSN: 10805826     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)